Clinical trial
A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases
NCT00096265 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 6, 2004
- Completion date
- April 1, 2012
- Enrollment
- 126 (actual)
- Sites
- 83
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic malignant neoplasm in the brain, recurrent non-small cell lung carcinoma, stage iv non-small cell lung cancer ajcc v7